PSIPW participated in the 2nd International Conference on Risk Assessment of Pharmaceuticals in the Environment (ICRAPHE 2019) which was held in Barcelona, Spain from 28 to 29 November 2019. The participation of three leading experts in the field was supported by a PSIPW grant.
Pharmaceutical contaminants are a growing problem and have become a leading topic for water management, water purification, surface water and groundwater research.
Back in 2012, PSIPW had the foresight to award the Water Management & Protection Prize to Dr. Damià Barceló, Professor at the Institute of Environmental Assessment and Water Studies in Barcelona and Director of the Catalan Institute of Water Research. He was honoured for demonstrating the widespread water pollution caused by a broad spectrum of pharmaceuticals and for developing new methods for the future risk assessment and management of emerging contaminants.
Now the problem of pharmaceutical contaminants has grown to be an integral theme for dedicated sessions at water and environmental science conferences, as well as a dedicated conference of its own.
The first ICRAPHE conference was organized in Paris from 8-9 September 2016 by Professor Yves Levi of the University Paris Sud and Faculty of Pharmacy, Catenay-Malabry, France and Academie Nationale de Pharmacie, Paris, France. Its success has led to the current conference as well as a planned third conference in Hangzhou China next year.
PSIPW awarded grants to three leading experts who gave keynote addresses at the conference. They were:
Yolanda Pico of the Faculty of Pharmacy, University of Valencia, Spain.
She presented: “Pharma Residues and Microplastics in Saudi Arabian Lakes and Pools Irrigated with Wastewaters: Bioaccumulation and Plant Uptake”.
Ajit Sarmah of the University of Auckland, New Zealand.
He presented: “Low-Cost Adsorbent for Environmental Remediation of Pharma Residues- How Resilient is the Approach?
Mario Carere of the Istituto Superiore di Sanità, Rome, Italy.
He presented: “Effect Based Methods for the Detection of Pharmaceutical Contamination in the Context of the Water Framework Directive”